Larvol Delta - CalciMedica-Announces-Independent-Safety-Review-Committee-Recommendation-to-Continue-Phase-2-Study-of-CM4620IE-in-Patients-with-Severe-COVID19-Pneumonia-on-LowFlow-Oxygen-Therapy

CM4620 - CalciMedica

http://www.globenewswire.com/news-release/2020/05/07/2029378/0/en/CalciMedica-Announces-Independent-Safety-Review-Committee-Recommendation-to-Continue-Phase-2-Study-of-CM4620-IE-in-Patients-with-Severe-COVID-19-Pneumonia-on-Low-Flow-Oxygen-Therap.html

May 7, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next